News and Announcements
YPB First Deal With Latest Channel Partner
- Published September 23, 2016 2:52PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
22nd September 2016, ASX Announcement
Highlights:
- Impact customer LaClinica for Skin & Body signed for YPB PROJECT solution
- FMCG packager Impact International announced as Channel Partner in July 2016
- Marketing campaign conducted by Impact in Augst 2016 Introducing YPB to its customer base
Brand Protection and Customer Engement solutions company YPB Group Limited (ASX: YPB) is pleased to announce that the channel partner Impact International has signed its first deal pertaining to YPB’s technology with its customer La Clinica for Skin & Body.
La Clinica for Skin & Body is a cosmeceutical skin care line with a focus on visible results, efficacy safety & organic ingredients.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
